Thomas P. Stossel is an American Cancer Society Professor of Medicine Emeritus at
Harvard Medical School, Honorary Physician in the Hematology Division of Brigham &
Women's Hospital, founding scientist of BioAegis Therapeutics, Visiting Scholar of
The American Enterprise Institute and cofounder of Options for Children in Zambia.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Private sector contributions to pharmaceutical science: thirty-five summary case histories.Am J Ther. 2010; 17: 101-120
- What are the respective roles of the public and private sectors in pharmaceutical innovation?.Health Aff. 2011; 30: 332-339
- Pharmaphobia: how the conflict of interest myth undermines American medical innovation.Rowman and Littlefield, Publishers, Lanham (MD), Boulder (CO), New York, London2015
- Innovation in the pharmaceutical industry: new estimates of R&D costs.J Health Econ. 2016; 47: 20-33
Article info
Publication history
Accepted:
June 29,
2016
Identification
Copyright
© 2016 Elsevier Inc. All rights reserved.
